Skip to content

Study on the Association between Mitochondrial Gene Mutations and Hypertension and Target Organ Damage

Study on the Association between Mitochondrial Gene Mutations and Hypertension and Target Organ Damage

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111020
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-10-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Observational group:None

Sponsors

The First Medical Center of the Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Hypertensive patients aged 18–80 years; 2. Conscious with good verbal communication ability; 3. Condition stable following routine treatment; 4. Has signed the informed consent form and voluntarily participates in this study.

Exclusion criteria

Exclusion criteria: 1. Age >80 years or <18 years; 2. Concurrent serious organic diseases of other systems, such as neurological or immune system disorders; 3. Concurrent malignancy; 4. Concurrent pregnancy.

Design outcomes

Primary

MeasureTime frame
Clinical information (including demographic data, medical history, and lifestyle factors);Mitochondrial gene sequencing;

Secondary

MeasureTime frame
Laboratory tests (including complete blood count, blood biochemistry, glycated hemoglobin, renin/aldosterone, etc.);

Countries

China

Contacts

Public ContactLi Zongbin

The First Medical Center of the Chinese PLA General Hospital

lizww@163.com+86 133 6639 3568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026